Abnormal atrial and ventricular development upon eMYH knockdown. (A-K) Morpholino was applied at HH12 (B-D) or HH14 (F-H), with harvesting at HH19 for eMYH knockdowns (C,D,G,H) and controls (A,B,E,F). Knockdowns at HH12/19 (C,D) and 14/19 (G,H) had thinner ventricular walls and reduced trabeculae in comparison with controls (A,B,E,F). Abnormal atrial septa were seen in the knockdowns, with either a knuckle-shaped outgrowth (arrowheads in C,G,J) or normally shaped but reduced septa (arrowheads in D,H,K) compared with controls (arrowheads in A,B,E,F,I). From gross morphological phenotypic studies, hearts shown in A-F and H were normal in size whereas that shown in G was enlarged. I, J and K are enlarged views of the boxed areas in D, F and G, respectively. (L-N) Morpholino was applied at HH14 and tissue was harvested at HH17. HH14/17 controls (L,M) had stage-appropriate septa (arrowheads) and eMYH knockdowns (N) had no discernable septum. Scale bars: 500 μm for A-H; 200 μm for I-K; 100 μm for L-M; At, atrium; OFT, outflow tract; SC, standard control; V, ventricle. Asterisks indicate trabeculae. Incubation periods: HH12, 50 hours; HH14, 54 hours; HH16, 57 hours; HH17, 62 hours; HH19, 81 hours.